Seroprevalence of hepatitis B and C virus markers among blood donors in Rio de Janeiro, Brazil, 1998-2005

Memorias do Instituto Oswaldo Cruz

Volumn 101, Issue 6, 2006, Pages 673-676

  Andrade, Ana F B ^a   Oliveira Silva, Michelle ^b   Silva, Suely G C ^b   Motta, Iara J F ^b   Bonvicino, Cibele R ^a,b  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

Author keywords

Blood donors; Brazil; Hepatitis B virus; Hepatitis C virus; Seroprevalence

Indexed keywords

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 33749652108     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762006000600016     Document Type: Article

References (22)

1. Almeida Neto C, Strauss E, Sabino EC, Sucupira MCA, Chamone D 2001. Significance of isolated hepatitis B core antibody in blood donors from São Paulo. Rev Inst Med Trop São Paulo 43: 203-208.
2. Arraes LC, Ximenes R, Andrieu J-M, Lu W, Barreto S, Pereira LMMB, Castelo A 2003. The biological meaning of anti-HBc positive results in blood donor: relation to HBV-DNA and to other serological markers. Rev Inst Med Trop São Paulo 45: 137-140.
3. Braga WSM, Silva EM, Souza RAB, Tosta CE 2005. Soroprevalência da infecção pelo vírus da hepatite B e pelo plasmódio em Lábrea, Amazonas: estimativa da ocorrência de prováveis coinfecções. Rev Soc Bras Med Trop 38: 218-223.
4. Chattopadhyay S, Rao S, Das BC, Singh NP, Kar P 2005. Prevalence of transfusion-transmitted virus infection in patients on maintenance hemodialysis from New Delhi, India. Hemodial Int 9: 362-366.
5. Chiavetta JA, Escobar M, Newman A, He Y, Driezen P, Deeks S, Hone DE, O'Brien SF, Sher G 2003. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000. CMAJ 169: 767-773.
6. Custer B, Sullivan SD, Hazlet TK, Iloeje U, Veenstra DL, Kowdley KV 2004. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38: S158-S168.
7. Da Fonseca JC, Brasil CM 2004. Hepatitis C virus infection in the Amazon Brazilian region. Rev Soc Bras Med Trop 37: 1-8.
8. th, Stramer SL 2002. Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population. Transfusion 42: 975-979.
9. Frider B 2000. Epidemiologia de la hepatitis C. Acta Gastroenterol Latinoam 30: 142-144.
10. Gonçales Junior FL 1998. Prevenção das hepatites póstransfusionais. In DT Covas, MA Zago (eds), Atualização em Hemoterapia, Gráfica Canavaci, Ribeirão Preto, SP.
11. Kao JH, Chen PJ, Lai MY, Chen DS 2002. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C. J Clin Microbiol 40: 4068-4071.
12. Ministério da Saúde 2004. Doenças Infecciosas e Parasitárias: Guia de Bolso, 4th ed., Departamento de Vigilância Epidemiológica, Brasília, p. 172-176.
13. Offergeld R, Faensen D, Ritter S, Hamouda O 2005. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing. Euro Surveill 10: 8-11.
14. Purow DB, Jacobson IM 2003. Slowing the progression of chronic hepatitis B: early antiviral therapy can help minimize complications. Postgrad Med 114: 65-76.
15. Rosini N, Mousse D, Spada C, Treitinger A 2003. Seroprevalence of HbsAg, Anti-HBc and Anti-HCV in Southern Brazil, 1999-2001. Braz J Infect Dis 7: 262-267.
16. Schmunis GA, Zicker F, Cruz JR, Cuchi P 2001. Safety of blood supply for infectious diseases in latin american countries, 1994-1997. Am J Trop Med Hyg 65: 924-930.
17. Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras R, Demir K, Avsar E, Mert A, Besisik F, Kaymakoglu S, Senturk H, Cakaloglu Y, Kalayci C, Okten A, Tozun N 2005. Sexual transmission of HCV between spouses. Am J Gastroenterol 100: 821-824.
18. Tosti ME, Solinas S, Prati D, Salvaneschi L, Manca M, Francesconi M, Ciuffreda M, Girelli G, Mele A 2002. An estimate of the current risk of transmitting blood-borne infections through blood transfusion in Italy. Br J Haematol 117: 215-219.
19. Treitinger A, Spada C, Ferreira LA, Neto MS, Reis M, Verdi JC, de Miranda AF, de Oliveira OV, Van der Sander Silveira M, Abdalla DS 2000. Hepatitis B and hepatitis C prevalence among blood donors and HIV-1 infected patients in Florianopolis-Brazil. Braz J Infect Dis 4: 192-196.
20. Wright TL, Hollander H, Pu X, Held MJ 1994. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 20: 1152-1155.
21. Zou S, Notari IV EP, Stramer SL, Wahab F, Musavi F, Dodd RY 2004. Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study. Transfusion 44: 1640-1647.
22. Zou S, Tepper M, Giulivi A 2000. Current status of hepatitis C in Canada. Can J Public Health 91: S10-5-S10-6.